Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

HiFiBiO Therapeutics (United States) | Researchclopedia

Back to institutions

HiFiBiO Therapeutics (United States)

Cambridge, Massachusettscompany

52

Works

5,927

Citations

29

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Top Researchers

Eric J. Alm Amgen (United States)

384 works88,879 citationsh-index: 96

Recent Research

HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering

Jiliang Zhao,Dongping Zhang,et al.

20260 citations

Monoclonal and Polyclonal Antibodies Research

Gut microbiota and health

Immune Cell Function and Interaction

Computational Drug Discovery Methods

Receptor Mechanisms and Signaling

Cancer Genomics and Diagnostics

Single-cell and spatial transcriptomics

Immune cells in cancer

Biosimilars and Bioanalytical Methods

Sean M. Gibbons University of Washington

230 works39,745 citationsh-index: 54

Matthew L. Albert

283 works39,585 citationsh-index: 84

Claire Duvallet Massachusetts Institute of Technology

73 works30,219 citationsh-index: 31

Qian Zhang BGI Group (China)

625 works22,754 citationsh-index: 67

Jean Wang University Health Network

311 works17,268 citationsh-index: 57

Immunogenic tumor cell death and T-cell-derived IFN-γ elicit tumoricidal macrophages to potentiate OX40 immunotherapy

Yanqin Liu,Jiliang Zhao,et al.

20260 citations

Development of synthetic introns for selective elimination of U2AF1 mutant MDS

Qian Zhang,Kuan-Ting Lin,et al.

20250 citations

949P Evaluation of HVEM and PD-L1 expression profile in tumors as potential predictive biomarkers for HFB200603, a BTLA antagonist, as monotherapy and in combination with tislelizumab

Maria J. de Miguel,Evelina Zurita Márquez,et al.

20250 citations

994P Potential predictive biomarkers of clinical benefit from Emunkitug (HFB200301) in combination with tislelizumab: Integrated analysis of tumor, peripheral blood, and patient treatment history

D. Roda Perez,Ashley Chung,et al.

20250 citations

CXCR5 as a Therapeutic Target in Autoimmune Diseases: Insights from Sjögren’s Syndrome

Germain Margall Ducos,Sophie Foulon,et al.

20250 citations